 |
Michael W. Fried, MD is Professor of Medicine and Director of Hepatology at the University of North Carolina at Chapel Hill. Dr. Fried has been involved with clinical and laboratory studies of hepatitis C since 1990 when he served for three years as a medical staff fellow in the Liver Diseases Section of the National Institutes of Health. Dr Fried has been the principal investigator on numerous Phase I, II and III clinical trials of various antiviral agents for chronic hepatitis B and hepatitis C. Since his appointment to UNC in 1998, Dr. Fried continues his commitment to the development of new and more effective treatments for these and other chronic liver diseases. Dr. Fried was recently inducted into the American Society of Clinical Investigation (ASCI), an honor society for clinical investigators. He is also a recipient of a career development award from the National Institutes of Health to provide mentorship to young clinical investigators at UNC. |
 |
Jama M. Darling, MD is Assistant Professor of Medicine at the University of North Carolina at Chapel Hill. She completed a residency in internal medicine in 1999 at UT Southwestern and a fellowship in gastroenterology in 2002 at Stanford University. Dr. Darling was awarded an AASLD advanced hepatology fellowship at the University of California San Francisco in 2003 where her focus was viral hepatitis. She was an Assistant Professor of Medicine at UCSF prior to joining the UNC team in 2005. Dr. Darling maintains a busy general hepatology practice and her research interests are viral immunology and HCV/HIV co-infection. |
 |
C. Thomas Nuzum, MD, is a Professor of Medicine at the University of North Carolina, Chapel Hill. Dr. Nuzum received undergraduate and medical degrees from Harvard University, and a M.A. in Natural Sciences from Cambridge University (U.K.). His internship and first year of residency were at the University of Kentucky Medical Center; senior residency and fellowship were at Peter Bent Brigham Hospital, Boston. After research on hepatic enzymes of urea synthesis and assistant professorship in gastroenterology at the University of Kentucky, he came to UNC as Department of Medicine liaison to the Area Health Education Centers (AHEC) Program. He became that program’s Associate Director for Clinical Affairs. He is now an active outpatient and consulting hepatologist, particularly in initial evaluation of patients with hepatitis C and other chronic liver diseases. |
 |
Donna Evon, PhD is Assistant Professor of Medicine and a Clinical Psychologist at the University of North Carolina at Chapel Hill. Dr. Evon completed her predoctoral internship and postdoctoral fellowship in the UNC School of Medicine, with specialty training in behavioral medicine and organ transplantation. She worked with patients with end stage liver disease, hepatitis C, and alcohol abuse. She joined the UNC Liver Program in 2004 and works with the hepatitis C clinical and research programs. Dr. Evon provides psychological evaluations for patients being considered for antiviral therapy and helps to manage the neuropsychiatric side effects of interferon-based therapy. Her research interests include the bio-psycho-social issues of living with hepatitis C and undergoing antiviral therapy. |
|
|
